Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2013 | 03-2013 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -551 | 0 | -12 | -18 | N/A |
| Net Acquisitions | N/A | N/A | 47 | 0 | N/A |
| Other Investing Activity | 31 | 0 | -220 | 0 | 543 |
| Investing Cash Flow | $-520 | $0 | $-185 | $-18 | $543 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -115 | 0 | 0 | 0 | -1,014 |
| Common Stock Issued | 7,370 | 7 | 0 | 23 | N/A |
| Other Financing Activity | -787 | -1 | 424 | -149 | 163 |
| Financing Cash Flow | $6,469 | $6 | $424 | $-126 | $-851 |
| Exchange Rate Effect | 22 | 0 | 101 | -26 | -42 |
| Beginning Cash Position | 18 | 14 | 3,143 | 5,937 | 11,450 |
| End Cash Position | 16,435 | 18 | 1,721 | 3,143 | 8,900 |
| Net Cash Flow | $2,195 | $4 | $-1,522 | $-2,769 | $-2,507 |
| Free Cash Flow | |||||
| Capital Expenditure | -556 | 0 | -12 | -18 | N/A |
| Free Cash Flow | -556 | 0 | -12 | -18 | 0 |